Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial.
Diabetes Care
; 45(7): e113-e115, 2022 07 07.
Article
in En
| MEDLINE
| ID: mdl-35613364
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Abelmoschus
/
Diabetes Mellitus, Type 2
/
Diabetic Nephropathies
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Diabetes Care
Year:
2022
Document type:
Article
Affiliation country:
China